What is lecanemab and how does it slow down Alzheimer's disease?

What is lecanemab and how does it slow down Alzheimer's disease?

  • Autor
  • Osa
      259
  • Avaldatud
      6. nov 2025
  • Kirjastaja
0 Hinnangud
0
Osa
259 of 261
Kestus
27 min
Keel
inglise
Vorming
Kategooria
Enesearendus

A new Health Canada-approved drug called lecanemab has been shown to slow early-stage Alzheimer's disease. Neurologist Dr. Sharon Cohen, who participated in phase three trials for the drug, explains why lecanemab is such a big deal.

For transcripts of The Dose, please visit: lnk.to/dose-transcripts. Transcripts of each episode will be made available by the next workday. For more episodes of this podcast, click this link.


Loe ja kuula

Astu lugude lõputusse maailma

  • Suurim valik eestikeelseid audio- ja e-raamatuid
  • Proovi tasuta
  • Loe ja kuula nii palju, kui soovid
  • Lihtne igal ajal tühistada
Device Banner Block-copy 894x1036
Cover for What is lecanemab and how does it slow down Alzheimer's disease?

Muud podcastid, mis võivad sulle meeldida ...